|
|
|
|
| LEADER |
02577cam a2200445 4500 |
| 001 |
PPN013483374 |
| 005 |
20240327055500.0 |
| 010 |
|
|
|a 3-540-57123-X
|b Berlin : alk. paper
|d 430 GPB
|
| 010 |
|
|
|a 0-387-57123-X
|b New York : alk. paper
|
| 020 |
|
|
|a US
|b 9344948
|
| 035 |
|
|
|a sib0563241
|
| 035 |
|
|
|a ocm29358406
|
| 100 |
|
|
|a 19940823d1994 k y0frey0103 ba
|
| 101 |
0 |
|
|a eng
|
| 102 |
|
|
|a DE
|
| 105 |
|
|
|a y z 001yy
|
| 106 |
|
|
|a r
|
| 200 |
1 |
|
|a The pharmacology of monoclonal antibodies
|f eds. Martin Rosenberg and Gordon P. Moore
|
| 210 |
|
|
|a Berlin
|a New York
|c Springer
|d 1994
|
| 215 |
|
|
|a 1 vol. (XXI-406 p.)
|d 25 cm
|
| 225 |
1 |
|
|a Handbook of experimental pharmacology
|x 0171-2004
|v 113
|
| 320 |
|
|
|a Bibliogr. Notes bibliogr. Index
|
| 327 |
1 |
|
|a Human monoclonal antibodies
|a Human monoclonal antibody technology / K. James
|a Recombinant therapeutic human monoclonal antibodies / J.W. Larrick, R. Balint
|a Transgenic approaches to human monoclonal antibodies / N. Lonberg
|a Genetically engineered monoclonal antibodies
|a Humanization of monoclonal antibodies / G.E. Mark, E.A. Padlan
|a Applications for Escherichia coli-derived humanized Fab' fragments: efficient construction of bispecific antibodies / P. Carter, M.L. Rodrigues, M.R. Shalaby
|a MAb conjugates and fusions
|a Immunotoxins / S.H. Pincus
|a Antibody-enzyme fusion proteins and bispecific antibodies / E. Haber
|a Three generations of recombinant CD4 molecules as anti-HIV reagents / A. Traunecker, K. Karjalainen
|a Combinatorial libraries
|a Chemical and biological approaches to catalytic antibodies / K.D. Janda, Y.-C. Jack Chen
|a Combinatorial approach to human antibodies / C.F. Barbas
|a Expression of MAbs/MAb fragments
|a Antibodies from Escherichia coli / A. Pluckthun
|a Structure, function and uses of antibodies from transgenic plants and animals / A. Hiatt, M. Hein
|
| 410 |
|
| |
|9 1130
|0 013375911
|t Handbook of experimental pharmacology
|x 0171-2004
|v 113
|
| 606 |
|
|
|3 PPN027880966
|a Anticorps monoclonaux
|2 rameau
|
| 606 |
|
|
|3 PPN040663426
|a Anticorps monoclonaux
|2 fmesh
|
| 606 |
|
|
|3 PPN028968263
|a Immunopharmacologie
|2 rameau
|
| 676 |
|
|
|a 615/.1 s
|v 20
|
| 680 |
|
|
|a QP905
|b .H3 vol. 113
|
| 686 |
|
|
|a W1
|b HA51L v.113 1994
|2 usnlm
|
| 686 |
|
|
|a QW 575
|b P536 1994
|2 usnlm
|
| 702 |
|
1 |
|3 PPN034292861
|a Rosenberg
|b Martin
|f 1951-....
|4 340
|
| 702 |
|
1 |
|a Moore
|b Gordon P.
|4 340
|
| 801 |
|
3 |
|a FR
|b Abes
|c 20070129
|g AFNOR
|
| 801 |
|
3 |
|a FR
|b SF
|g AFNOR
|
| 801 |
|
1 |
|a US
|b OCLC
|g AACR2
|
| 801 |
|
2 |
|a FR
|b AUROC
|g AFNOR
|
| 930 |
|
|
|5 441092101:298870940
|b 441092101
|a QW 575 ROS
|j u
|
| 979 |
|
|
|a SAN
|
| 998 |
|
|
|a 209530
|
Nantilus
